Login / Signup

Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity.

Julie B HjerpstedAnne FlintAshley BrooksMads B AxelsenTrine KvistJohn E Blundell
Published in: Diabetes, obesity & metabolism (2017)
Semaglutide improved fasting and postprandial glucose and lipid metabolism. Overall gastric emptying was similar to that with placebo; however, the observed first-hour delay with semaglutide may contribute to a slower entry of glucose into the circulation.
Keyphrases
  • blood glucose
  • blood pressure
  • glycemic control
  • insulin resistance
  • metabolic syndrome
  • type diabetes
  • weight loss
  • fatty acid
  • adipose tissue
  • clinical trial
  • skeletal muscle